We still don't know whether inclisiran protects patients
The UK government’s new policy to fast track “innovative” drugs into the NHS has been called a “spectacular failure” because of how a test case using the cholesterol lowering drug inclisiran was received.1 In January 2020, I sent The BMJ a response saying that it was at that …